Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zoetis Inc Class A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,072,076
  • Shares Outstanding, K 481,820
  • Annual Sales, $ 5,307 M
  • Annual Income, $ 864,000 K
  • 36-Month Beta 1.02
  • Price/Sales 8.31
  • Price/Cash Flow 31.26
  • Price/Book 22.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.77
  • Number of Estimates 5
  • High Estimate 0.79
  • Low Estimate 0.75
  • Prior Year 0.65
  • Growth Rate Est. (year over year) +18.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.25 +10.70%
on 07/25/18
93.67 -1.61%
on 08/09/18
+6.87 (+8.05%)
since 07/20/18
3-Month
82.40 +11.84%
on 05/29/18
93.67 -1.61%
on 08/09/18
+7.76 (+9.19%)
since 05/18/18
52-Week
60.65 +51.95%
on 08/21/17
93.67 -1.61%
on 08/09/18
+31.41 (+51.70%)
since 08/18/17

Most Recent Stories

More News
Shares of Theravance B Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (TBPH , ZTS , PCRX , ITCI , CTLT )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

TBPH : 26.95 (-0.77%)
ZTS : 92.16 (+0.75%)
PCRX : 45.00 (-2.91%)
Zoetis (ZTS) Beats on Q2 Earnings & Sales, Updates '18 View

Zoetis second-quarter 2018 results exceed both earnings and sales estimates. The company completes the acquisition of Abaxis, Inc.

ZTS : 92.16 (+0.75%)
GILD : 72.36 (-0.77%)
REGN : 374.80 (+0.14%)
VNDA : 21.10 (-3.43%)
Zoetis (ZTS) Q2 Earnings and Revenues Beat Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 8.45% and 2.21%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

ZTS : 92.16 (+0.75%)
Zoetis Announces Second Quarter 2018 Results

--Reports Adjusted Net Income of $375 Million, or Adjusted Diluted EPS of $0.77, for Second Quarter 2018

ZTS : 92.16 (+0.75%)
Drug Stock Q2 Earnings Releases on Aug 2: ZTS, REGN & More

Let's see how these pharma/biotech stocks are poised ahead of their scheduled results on Aug 2.

RARE : 77.36 (-0.95%)
BMRN : 99.03 (-1.96%)
ALNY : 96.37 (+1.89%)
ZTS : 92.16 (+0.75%)
REGN : 374.80 (+0.14%)
PFE : 42.33 (+0.57%)
SNY : 42.22 (+0.43%)
Zoetis Completes Acquisition of Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments

--Enhances Zoetis' presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years(1)

ABAX : 83.00 (-0.11%)
ZTS : 92.16 (+0.75%)
Zoetis (ZTS) Gears Up for Q2 Earnings: What's in Store?

We expect Zoetis (ZTS) to throw more light on its Abaxis acquisition plans and other pipeline updates during second-quarter 2018 earnings call.

ENDP : 15.91 (+1.73%)
ZTS : 92.16 (+0.75%)
REGN : 374.80 (+0.14%)
PCRX : 45.00 (-2.91%)
Veterinary Diagnostics Market to Hit 9.3% CAGR to 2023, Led by Animal Health Expenditure and Pet Insurance

ReportsnReports added veterinary diagnostics market research, it includes the companies like IDEXX Laboratories, Inc. (U.S.), Abaxis, Inc. (U.S.), Neogen Corporation (U.S.), Heska Corporation (U.S.), Thermo...

ABAX : 83.00 (-0.11%)
ZTS : 92.16 (+0.75%)
IDXX : 242.48 (-0.42%)
QGEN : 37.74 (+1.23%)
NEOG : 85.19 (+1.27%)
Pre-Market Research Reports on Generic Drugs Stocks -- Tricida, Zoetis, Adamas Pharma, and Allergan

If you want a free Stock Review on TCDA, ZTS, ADMS, and AGN sign up now at https://stocktraderreport.com/registration/. On Friday, key US indices were bearish as the NASDAQ Composite finished the trading...

ADMS : 21.84 (-2.63%)
ZTS : 92.16 (+0.75%)
AGN : 190.75 (+2.77%)
TCDA : 23.50 (-1.05%)
CTLT vs. ZTS: Which Stock Is the Better Value Option?

CTLT vs. ZTS: Which Stock Is the Better Value Option?

CTLT : 41.29 (+0.88%)
ZTS : 92.16 (+0.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ZTS with:

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

2nd Resistance Point 93.11
1st Resistance Point 92.63
Last Price 92.16
1st Support Level 91.64
2nd Support Level 91.13

See More

52-Week High 93.67
Last Price 92.16
Fibonacci 61.8% 81.06
Fibonacci 50% 77.16
Fibonacci 38.2% 73.26
52-Week Low 60.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar